- 专利标题： COMPOSITIONS OF CLOFAZIMINE AND AMIKACIN FOR PULMONARY ADMINISTRATION IN THE TREATMENT OF RESPIRATORY DISEASES
-
申请号： US18566008申请日： 2022-06-01
-
公开(公告)号： US20240299379A1公开(公告)日： 2024-09-12
- 发明人: Hugh D.C. SMYTH , Ashlee D. BRUNAUGH
- 申请人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- 申请人地址： US TX Austin
- 专利权人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- 当前专利权人： BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
- 当前专利权人地址： US TX Austin
- 国际申请： PCT/US2022/031852 2022.06.01
- 进入国家日期： 2023-11-30
- 主分类号： A61K31/498
- IPC分类号： A61K31/498 ; A61K9/00 ; A61K31/7036
摘要：
The present disclosure provides pharmaceutical compositions of clofazimine and amikacin that may be administered via inhalation. These compositions may be used to treat one or more diseases or disorders such as a bacterial infection or other lung diseases or disorders. These compositions may be made using a spray drying method that results in deposition of the clofazimine onto the amikacin.
信息查询
IPC分类:
